Expired
Lead Plaintiff Deadline
Sep 19, 2025
Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that Alto Neuroscience, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) The Company’s product pipeline, ALTO-100, was less effective in treating major depressive disorder than defendants had led investors to believe; (ii) accordingly, ALTO-100’s clinical, regulatory, and commercial prospects were overstated; (iii) as a result, Alto’s business and/or financial prospects were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
In order to be eligible to join the ANRO class action lawsuit, you must have incurred a loss on shares of Alto Neuroscience, Inc. purchased during the class period listed above.
If you suffered a loss in Alto Neuroscience, Inc. during the relevant time frame, you have until September 19, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP
